- Reports
- Lisa Graves
- Mary Bottari
- Wendell Potter
- Brendan Fischer
- Rebekah Wilce
- Sara Jerving
- Harriet Rowan
- Jonathan Rosenblum
- Will Dooling
- Emily Osborne
- Abdul Raziq
- Guest Contributor
- Archives
- Alex Carlin
- Anne Landman
- Bob Burton
- Chelsea Lawliss
- Diane Farsetta
- Eric Carlson
- Jennifer Page
- Jessica Opoien
- Jill Richardson
- John Stauber
- Judith Siers-Poisson
- Maxwell Abbott
- Megha Desai
- Monica Chang
- Osasumwen Izevbigie
- Patrick Moran
- Rebecca Sandler
- Ross Wolfarth
- Sarah Olson
- Sheldon Rampton
- Steve Horn
- Take Action
- Latest News
- Media
- SourceWatch
- Publications
- About Us
- Why Donate?
PR Industry Can Learn Lesson From Anti-Biotech Activists
Ross Irvine, corporate activist and president of ePublic Relations, points out how business PR can learn from anti-biotech activists and NGOs. Irvine recommends taking a broader view of the issue, going beyond traditional allies and PR activities. According to Irvine, "With creative thinking a great deal of synergy among biotech and other issues is possible and essential."
Main Source:
ePublic Relations, July 2001 



